Literature DB >> 4150944

A possible interaction of quipazine with central dopamine structures.

M Grabowska, L Antkiewicz, J Michaluk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4150944     DOI: 10.1111/j.2042-7158.1974.tb12828.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  12 in total

1.  Quipazine-induced stimulus control in the rat.

Authors:  J C Winter
Journal:  Psychopharmacology (Berl)       Date:  1979-02-28       Impact factor: 4.530

2.  Metoclopramide antagonism of 5-hydroxytryptophan-induced "wet-dog" shake behaviour in the rat.

Authors:  J R Fozard; M G Palfreyman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-06       Impact factor: 3.000

3.  A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.

Authors:  A R Green; J E Hall; A R Rees
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

4.  The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced increases in locomotor activity.

Authors:  J J Feigenbaum; J Yanai; H L Klawans
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

5.  The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced locomotor activity.

Authors:  J J Feigenbaum; J Yanai; H L Klawans
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

6.  Thyrotropin releasing hormone (TRH): restoration of oxotremorine tremor in mice. Comparison with quipazine, a serotoninergic and dopaminergic stimulant.

Authors:  H Kruse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-07       Impact factor: 3.000

7.  The central antiserotonergic action of mianserin.

Authors:  J Maj; H Sowińska; L Baran; L Gancarczyk; A Rawłów
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

8.  Evidence of a preferential role of brain serotonin in the mechanisms leading to naloxone-precipitated compulsive jumping in morphine-dependent rats.

Authors:  L Cervo; C Rochat; S Romandini; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Neuroendocrine effects of quipazine in man in health state or with neurological disorders.

Authors:  E A Parati; P Zanardi; D Cocchi; T Caraceni; E E Müller
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

Review 10.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.